Bacterial meningitis: The role of transforming growth factor-beta in innate immunity and secondary brain damage

Neurodegenerative Diseases

Volumn 4, Issue 1, 2007, Pages 43-50

  Malipiero, Ursula ^a   Koedel, Uwe ^b   Pfister, Walter ^b   Fontana, A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chemotaxis; Endothelium; Inflammation; Leukocytes; Vasculitis

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

BACTERIAL MENINGITIS; BRAIN DAMAGE; DISULFIDE BOND; HUMAN; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MACROPHAGE ACTIVATION; PATHOPHYSIOLOGY; PHENOTYPE; PLEOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BRAIN INJURIES; CYTOKINES; HUMANS; IMMUNITY, NATURAL; MENINGITIS, BACTERIAL; MONOCYTES; NEUTROPHILS; TRANSFORMING GROWTH FACTOR BETA;

EID: 34247120545     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000100358     Document Type: Review

References (49)

1. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556.
2. Kastenbauer S, Pfister HW: Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003;126:1015-1025.
3. Zwahlen A, Nydegger UE, Vaudaux P, Lambert PH, Waldvogel FA: Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis 1982;145:635-646.
4. Medzhitov R, Janeway C Jr: The Toll receptor family and microbial recognition. Trends Microbiol 2000;8:452-456.
5. Koedel U, Rupprecht T, Angele B, Heesemann J, Wagner H, Pfister HW, Kirschning CJ: MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain 2004;127:1437-1445.
6. Paul R, Koedel U, Winkler F, Kieseier BC, Fontana A, Kopf M, Hartung HP, Pfister HW: Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 2003;126:1873-1882.
7. Winkler F, Koedel U, Kastenbauer S, Pfister HW: Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J Infect Dis 2001;183:1749-1759.
8. Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Hollander GA: Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 2000;31:80-84.
9. Kastenbauer S, Koedel U, Becker BF, Pfister HW: Oxidative stress in bacterial meningitis in humans. Neurology 2002;58:186-191.
10. Koedel U, Winkler F, Angele B, Fontana A, Pfister HW: Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 2002;22:39-49.
11. Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer E, Fontana A: T cell suppressor factor from human glioblastoma cells is a 12.5-kD protein closely related to transforming growth factor-beta. EMBO J 1987;6:1633-1636.
12. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert JM, Bodmer S, Fontana A, Hofer E: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J 1987;6:3673-3677.
13. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA: Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
14. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
15. Leveen P, Larsson J, Ehinger M, Cilio CM, Sundler M, Sjostrand LJ, Holmdahl R, Karlsson S: Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002;100:560-568.
16. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J: Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 2000;12:201-210.
17. Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002;109:41-50.
18. Boutard V, Havouis R, Fouqueray B, Philippe C, Moulinoux JP, Baud L: Transforming growth factor-beta stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J Immunol 1995;155:2077-2084.
19. Turner M, Chantry D, Katsikis P, Berger A, Brennan FM, Feldmann M: Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur J Immunol 1991;21:1635-1639.
20. Suzumura A, Sawada M, Yamamoto H, Marunouchi T: Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 1993;151:2150-2158.
21. Imai K, Takeshita A, Hanazawa S: Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infect Immun 2000;68:2418-2423.
22. Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M: Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 2005;280:5491-5495.
23. Tridandapani S, Wardrop R, Baran CP, Wang Y, Opalek JM, Caligiuri MA, Marsh CB: TGF-beta 1 suppresses myeloid Fc gamma receptor function by regulating the expression and function of the common gamma-subunit. J Immunol 2003;170:4572-4577.
24. Bottalico LA, Wager RE, Agellon LB, Assoian RK, Tabas I: Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 1991;266:22866-22871.
25. Han J, Hajjar DP, Tauras JM, Feng J, Gotto AM Jr, Nicholson AC: Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J Biol Chem 2000;275:1241-1246.
26. Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992;267:23301-23308.
27. Werner F, Jain MK, Feinberg MW, Sibinga NE, Pellacani A, Wiesel P, Chin MT, Topper JN, Perrella MA, Lee ME: Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 2000;275:36653-36658.
28. Tsunawaki S, Sporn M, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-beta. Nature 1988;334:260-262.
29. Perrella MA, Hsieh CM, Lee WS, Shieh S, Tsai JC, Patterson C, Lowenstein CJ, Long NC, Haber E, Shore S, Lee ME: Arrest of endotoxin-induced hypotension by transforming growth factor beta1. Proc Natl Acad Sci USA 1996;93:2054-2059.
30. Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, Bratton DL, Henson PM: Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J Biol Chem 2002;277:14884-14893.
31. Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-161.
32. Park SK, Yang WS, Lee SK, Ahn H, Park JS, Hwang O, Lee JD: TGF-beta(1) down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells. Nephrol Dial Transplant 2000;15:596-604.
33. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR: Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 1996;157:360-368.
34. Tang T, Frenette PS, Hynes RO, Wagner DD, Mayadas TN: Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J Clin Invest 1996;97:2485-2490.
35. Gamble JR, Vadas MA: Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta. Science 1988;242:97-99.
36. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 1991;138:1097-1101.
37. Gresham HD, Ray CJ, O'Sullivan FX: Defective neutrophil function in the autoimmune mouse strain MRL/lpr: potential role of transforming growth factor-beta. J Immunol 1991;146:3911-3921.
38. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB: Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-5792.
39. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM: Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 1990;171:231-247.
40. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999;18:1280-1291.
41. Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, Davidson JM, Nanney LB, Lucas C, Townes AS: Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med 1991;173:1121-1132.
42. Cui X, Zeni F, Vodovitz Y, Correa-de-Araujo R, Quezado M, Roberts A, Wahl S, Danner RL, Banks SM, Gerstenberger E, Fitz Y, Natanson C, Eichacker PQ: TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats. Cytokine 2003;24:115-127.
43. Huang CC, Chang YC, Chow NH, Wang ST: Level of transforming growth factor beta 1 is elevated in cerebrospinal fluid of children with acute bacterial meningitis. J Neurol 1997;244:634-638.
44. Malipiero U, Koedel U, Pfister H-W, Levéen P, Bürki K, Reith W, Fontana A: TGFbeta receptor II gene deletion in leukocytes prevents cerebral vasculitis in bacterial meningitis. Brain 2006;129:2404-2415.
45. McCartney-Francis N, Jin W, Wahl SM: Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-beta 1 signaling pathway. J Immunol 2004;172:3814-3821.
46. Giampaolo C, Scheld M, Boyd J, Savory J, Sande M, Wills M: Leukocyte and bacterial interrelationships in experimental meningitis. Ann Neurol 1981;9:328-333.
47. Tauber MG, Kennedy SL, Tureen JH, Lowenstein DH: Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kD heat shock protein. Am J Pathol 1992;141:53-60.
48. Tauber MG, Borschberg U, Sande MA: Influence of granulocytes on brain edema, intracranial pressure, and cerebrospinal fluid concentrations of lactate and protein in experimental meningitis. J Infect Dis 1988;157:456-464.
49. Felgenhauer K, Kober D: Apurulent bacterial meningitis (compartmental leucopenia in purulent meningitis). J Neurol 1985;232:157-161.